Prof. Dr. Aydoğan Aydoğdu

1.Tasci I, Cintosun U, Safer U, Naharci MI, Bozoglu E, Aydogdu A, Doruk H. Assessment of geriatric predictors of adherence to Zoledronic acid treatment for osteoporosis: a prospective follow-up study. Acta Clin Document. 2018;73:237-243.

2.Increased Endothelial Dysfunction and Insulin Resistance in Patients with Klinefelter Syndrome. Haymana C, Aydogdu A, Demirci I, Dinc M, Demir O, Torun D, ​​Yesildal F, Meric C, Basaran Y, Sonmez A, Azal O. Endocr Metab Immune Disord Drug Targets. 2018;18(4):401-406.

3.Haymana C, Aydoğdu A, Soykut B, Erdem O, Ibrahimov T, Dinc M, Meric C, Basaran Y, Sonmez A, Azal O., Oxidative stress status in congenital hypogonadism: an appraisal. Toxicol Mech Methods. 2017 May 2:1-7. doi: 10.1080/15376516.2017.1320693.

4.Haymana C, Sonmez A, Aydogdu A, Tapan S, Basaran Y, Meric C, Baskoy K, Taslipinar A, Yilmaz MI, Azal O., Effect of Testosterone Replacement Therapy on Vitamin D and FGF-23 Levels in Congenital Hypogonadism. Endocrynol Pol. 2017 Feb 23. doi: 10.5603/EP.a2017.0009

5.Haymana C, Sonmez A, Aydogdu A, Tapan S, Basaran Y, Meric C, Baskoy K, Dinc M, Yazici M, Taslipinar A, Barcin C, Yilmaz MI, Bolu E, Azal O. Visceral adiposity index and triglyceride/ high-density lipoprotein cholesterol ratio in hypogonadism. Arch Endocrinol Metab. 2017 Feb 13:0. doi: 10.1590/2359-399700000236.

6.Sönmez A, Dinç M, Taşlıpınar A, Aydoğdu A, Meriç C, Başaran Y, Haymana C, Demir O, Yılmaz İ, Azal Ö. Add on Exenatide Treatment is Beneficial in Poorly Controlled Obese Type 2 Diabetics under Intensive Insulin Regimens. Exp Clin Endocrinol Diabetes. 2017 Apr;125(4):256-261

7.Aydogdu A, Swerdloff RS. Emerging medication for the treatment of male hypogonadism. Expert Opin Emerg Drugs. 2016 Sep;21(3):255-66

8.Tasci I, Safer U, Cintosun U, Bozoglu E, Naharci I, Aydogdu A, Meric C, Doruk H. Zoledronic Acid Use and Risk of Cognitive Decline among Elderly Women and Men with Osteoporosis. Endocr Metab Immune Disord Drug Targets. 2016;16(1):32-8.

9.Bayram F, Elbuken G, Korkmaz C, Aydogdu A, Karaca Z, Cakır I. The Effects of Gonadotropin Replacement Therapy on Metabolic Parameters and Body Composition in Men with Idiopathic Hypogonadotropic Hypogonadism. Horm Metab Res. 2016 Feb;48(2):112-7.

1. Aydogdu A, Haymana C, Soykut B, Erdem O, Basaran Y, Baskoy K, Dinc M, Taslipinar A, Sonmez A, Bolu E, Azal O. Trace Element Levels in Congenital Hypogonadotrophic Hypogonadism. Biol Trace Elem Res. 2016 May;171(1):26-32.

11.Sonmez A, Haymana C, Aydogdu A, Tapan S, Basaran Y, Meric C, Baskoy K, Dinc M, Yazici M, Taslipinar A, Barcin C, Yilmaz MI, Bolu E, Azal O. Endothelial dysfunction, insulin resistance and inflammation in congenital hypogonadism, and the effect of testosterone replacement. Endocr J. 2015;62(7):605-13.

12.Osteoprotegerin, fibroblast growth factor 23, and vitamin D3 levels in male patients with hypogonadism. Meric C, Sonmez A, Aydogdu A, Tapan S, Haymana C, Basaran Y, Baskoy K, Sertoglu E, Taslipinar A, Bolu E, Azal O. Horm Metab Res. 2014; 46: 955-958.

13.Combined choroidal neovascularization and hypopituitarism in a patient with homozygous mutation in methylenetetrahydrofolate reductase gene. Aydogdu A, Haymana C, Baskoy K, Durukan AH, Ozgur G, Azal O. J Res Med Sci. 2014;19: 75-79.

14.Comparison of estimated GFR equations based on serum cystatin C alone and in combination with serum creatinine in patients with coronary artery disease. Doğaner YÇ, Aydoğan Ü, Rohrer JE, Aydoğdu A, Çaycı T, Barçın C, Sağlam K. Anadolu Kardiyol Journal. 2014; 16. doi: 10.5152/akd.2014.5535.

15.Effects of valsartan treatment on serum ghrelin level and left ventricular mass index in patients with untreated primary hypertension. Meriç C, Aydoğdu A, Taşçı İ, Deniz F, Baysan O, Serdar M, Sağlam K, Azal Ö. Anadolu Cardiyol Journal. 2014; 14: 234-238.

16.Relationship of cystatin C with coronary artery disease and its severity. Doganer YC, Aydogan U, Aydogdu A, Aparci M, Akbulut H, Nerkiz P, Turker T, Cayci T, Barcin C, Saglam K. Coron Artery Dis. 2013; 24:119-126.

17.The effect of levothyroxine replacement therapy on lipid profile and oxidative stress parameters in patients with subclinical hypothyroid. Mutlu S, Parlak A, Aydogan U, Aydogdu A, Soykut B, Akay C, Saglam K, Taslipinar A. Arch Pharm Res. 2013 Aug 8.

18.Cognitive and functional influences of vildagliptin, a DPP-4 inhibitor, added to ongoing metformin therapy in elderly with type 2 diabetes. Tasci I, Naharci MI, Bozoglu E, Safer U, Aydogdu A, Yilmaz BF, Yilmaz G, Doruk H. Endocr Metab Immune Disord Drug Targets. 2013; 13: 256-263.

19.HDL cholesterol subfractions and the effect of testosterone replacement in hypogonadism. Bolu E, Sonmez A, Tapan S, Taslipinar A, Aydogdu A, Meric C, Basaran Y, Uckaya G, Serdar M, Kurt I, Azal O. Horm Metab Res. 2013; 45:443-448.

20.Effects of three different medications on metabolic parameters and testicular volume in patients with hypogonadotropic hypogonadism: 3-year experience. Aydogdu A, Bolu E, Sonmez A, Tasci I, Haymana C, Acar R, Meric C, Taslipinar A, Ozgurtas T, Azal O. Clin Endocrinol (Oxf). 2013; 79: 243-251.

21.Brain derived neurotrophic factor (BDNF) in cardiometabolic physiology and diseases. Taşçı İ, Kabul HK, Aydoğdu A. Anadolu Kardiyol Journal. 2012; 12: 684-688.

22.Increased frequency of anxiety, depression, quality of life and sexual life in young hypogonadotropic hypogonadal males and impacts of testosterone replacement therapy on these conditions. Aydogan U, Aydogdu A, Akbulut H, Sonmez A, Yuksel S, Basaran Y, Uzun O, Bolu E, Saglam K. Endocr J. 2012; 59: 1099-1105.

23.Increase in subcutaneous adipose tissue and fat free mass in women with polycystic ovary syndrome is related to impaired insulin sensitivity. Aydogdu A, Tasci I, Kucukerdonmez O, Tapan S, Aydogdu S, Aydogan U, Sonmez A, Yazici M, Azal O. Gynecol Endocrinol. 2013 Feb;29(2):152-5.

24.Women with polycystic ovary syndrome have increased plasma chitotriosidase activity: a pathophysiological link between inflammation and impaired insulin sensitivity? Aydogdu A, Tasci I, Tapan S, Sonmez A, Aydogan U, Akbulut H, Uckaya G, Aydogdu S, Basaran Y, Meric C, Taslipinar A, Kurt I, Azal O. Exp Clin Endocrinol Diabetes. 2012; 120:261-265.

25.The relationship of epicardial adipose tissue thickness to clinical and biochemical features in women with polycystic ovary syndrome. Aydogdu A, Uckaya G, Tasci I, Baysan O, Tapan S, Bugan B, Serdar M, Akbulut H, Aydogan U, Sonmez A, Aydogdu S, Kutlu M. Endocr J. 2012; 59: 509-16.

26.Abdominal obesity is associated with a lower ankle-brachial index in women with polycystic ovary syndrome. Dogan MI, Tasci I, Bulucu F, Aydogdu A, Acar R, Ceyhan T, Koc B, Demir O, Gezer M, Saglam K. Angiology. 2013; 64:105-11.

27.High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome. Aydogdu A, Tasci I, Tapan S, Basaran Y, Aydogan U, Meric C, Sonmez A, Aydogdu S, Akbulut H, Taslipinar A, Uckaya G, Azal O. Gynecol Endocrinol. 2012; 28:722-725.

28.Metabolic syndrome and the effect of testosterone treatment in young men with congenital hypogonadotropic hypogonadism. Sonmez A, Haymana C, Bolu E, Aydogdu A, Tapan S, Serdar M, Altun B, Barcin C, Taslipinar A, Meric C, Uckaya G, Kutlu M. Eur J Endocrinol. 2011 May;164(5):759-64.

1. Chitotriosidase activity predicts endothelial dysfunction in type-2 diabetes mellitus. Sonmez A, Haymana C, Tapan S, Safer U, Celebi G, Ozturk O, Genc H, Dogru T, Tasci I, Erdem G, Taslipinar A, Aydogdu A, Yilmaz MI, Kurt I, Kutlu M. Endocrine. 2010; 37: 455-459.

30.The accuracy of home glucosemeters in hypoglycemia. Sonmez A, Yilmaz Z, Uckaya G, Kilic S, Tapan S, Taslipinar A, Aydogdu A, Yazici M, Yilmaz MI, Serdar M, Erbil MK, Kutlu M. Diabetes Technol Ther. 2010; 12: 619-626.

31.HDR syndrome (hypoparathyroidism, sensorineural deafness and renal disease) accompanied by renal tubular acidosis and endocrine abnormalities. Taslipinar A, Kebapcilar L, Kutlu M, Sahin M, Aydogdu A, Uckaya G, Azal O, Bolu E, Ibrahim Aydin H. Intern Med. 2008;47(11):1003-7.

32.The relationship between severity of coronary artery disease and plasma level of vascular endothelial growth factor. Kucukardali Y, Aydogdu S, Ozmen N, Yonem A, Solmazgul E, Ozyurt M, Cingozbay Y, Aydogdu A. Cardiovasc Revasc Med. 2008; 9: 66-70.

33.Effect of Helicobacter pylori infection and eradication therapy on interleukin-6 levels in patients with Familial Mediterranean Fever. Ozel AM, Demirturk L, Aydogdu A, Gultepe M, Yazgan Y, Imirzalioglu N, Gurbuz AK, Narin Y. Int J Clin Pract. 2008; 62:754-761.

Papers presented at international scientific meetings and published in proceedings books (verbal-poster)

1.U.S. Aydoğan, H Akbulut, DE Gök, YC Doğaner, O. Sarı, M.İ. Yılmaz, Z. Şenses, M. Kuşkucu, A. Aydoğdu, K. Sağlam, “The prevalence of anti-HCV and HbsAg in hemodialysis patients,” in the “Congress Book and Abstracts” paper within The 3rd Eurasia Congress Of Infectious Diseases conference. Eurasia Congress Of Infectious Diseases”, 208 pp., Baku, Azerbaijan, 01-04 October 2009

2.U.S. Aydoğan, H. Akbulut, DE Gök, YC Doğaner, O. Sarı, M.İ. Yılmaz, Z. Şenses, M. Kuşkucu, A. Aydoğdu, K. Sağlam, “Hemodialysis patients carrying nasal staphylococcus aureus and meticilin resistance.” ., Baku, Azerbaijan, October 2009

3 A. Sönmez, Z. Yılmaz, G. Üçkaya, S. Tapan, A. Taşlıpınar, A. Aydoğdu, M. Yazıcı, H. Turan, E. Bolu, O. Azal, A. Çorakçı, M. Kutlu., 20th World Diabetes Congress conference, “Are glucometers sensitive enough to detect hypoglycemia?”, 379 pp., Montreal, Canada, October 2009

4.A. Aydoğdu, H. Akbulut, G. Üçkaya, A. Taşlıpınar, A. Sönmez, U. Aydoğan, M. Kutlu, “Carcaneal spur incidence is increased in patients with type 2” in the “Endocrine Abstracts” paper within the 12th European Congress of Endocrinology conference diabetes mellitus”, p320 pp., Prague, Czech Republic, April, 2010

5 A. Aydogdu, O. Küçükerdönmez, G. Üçkaya, A. Taşlıpınar, E. Bolu, A. Sönmez, U. Aydoğan, M. Kutlu, 12th European Congress Of Endocrinology, “Waist circumference does not reflect body fat distribution and” in the “Endocrine Abstracts” proceedings book. insulin resistance in young male patients with idiopathic hypogonadotropic Hypogonadism”, p697 pp., Prague, Czech Republic, April 2010

6.A. Sönmez, C. Haymana, E. Bolu, S. Tapan, C. Barçın, A. Aydoğdu, A.Taşlıpınar, M. Kutlu, within the scope of the 12th European Congress Of Endocrinology conference, “Searching for the metabolic syndrome criteria” in the “Endocrine Abstracts” booklet in young adults with hypogonadism”, P148 pp., Prague, Czech Republic, April 2010

7.MY Yarpuz, U. Aydoğan, O. Sarı, A. Aydoğdu, G . Üçkaya, K. Sağlam., “The effect of thyroid replacement therapy to levels of anxiety and depression in subclinical hypothyroid patients.”, in the “Abstracts’ Book” paper within the 2nd Congress Of Association Of General Practice/Family Medicine Of South Easth Europe conference. 198 pp., Antalya, Turkey, April 2010

8.U. Aydoğan H. Akbulut, A. Parlak, O. Sarı, A. Aydoğdu, C. Barçın, K. Sağlam., “Coronary artery disease, comorbid diseases and pharmaceutical drug usage.”, 384 pp., Cancun, Mexico, May 2010

9.U. Aydoğan, H. Akbulut, A. Aydoğdu, YC Doğaner, E. Bolu, K. Sağlam, 2nd Congress Of Association Of General Practice/Family Medicine Of South Easth Europe conference in the “Complications and comorbid diseases in” booklet “Abstracts’ Book” type 2 diabetic patients.”, 221 pp., Antalya, Turkey, April 2010

10.A. Aydoğdu, U. Aydoğan, H. Akbulut, O. Sarı, E. Bolu, K. Sağlam., 2nd Congress Of Association Of General Practice/Family Medicine Of South Easth Europe conference in the “Anxiety levels” in the “Abstracts’ Book” booklet. patients diagnosed with and being treated for hypogonadism.”, 221 pp., Antalya, Turkey, April 2010

11.A. Aydoğdu, S. Aydoğdu, U. Aydoğan, C. Meriç, H. Akbulut, S. Yüksel, O. Sarı, G. Üçkaya, A. Sönmez, A. Taşlıpınar, M. Kutlu., 2nd International Meeting Of Hypertension And Diabetes “The frequency of prediabetes and diabetes mellitus in young obese male adolescents” in the “Abstract Book” booklet of the Primary Care conference, 57 pp., Istanbul, Turkey, April 2011

12.H. Akbulut, U. Aydoğan, A. Aydoğdu, P. Nerkiz, C. Barçın, YC Doğaner, T. Türker, K. Sağlam., 2nd International Meeting of Hypertension And Diabetes Primary Care within the “Abstract Book” booklet “Comparison of the results of elective angiography with exercise stress testing results”, 56 pp., Istanbul, Turkey, April 2011

13.YC Doğaner, U. Aydoğan, A. Aydoğdu, P. Nerkiz, O. Sarı, H. Akbulut, C. Barçın, K. Sağlam, K. “Abstract Book” within the 2nd International Meeting Of Hypertension And Diabetes Primary Care. “Relationship between diabetes mellitus and coronary artery disease” in the proceedings booklet, 53 pp., Istanbul, Turkey, April 2011

14.A. Sonmez, C. Haymana, E. Bolu, A. Aydogdu, S. Tapan, M. Serdar, B. Altun, C. Barcin, A. Taslipinar, C. Meric, G. Uckaya, M. Kutlu., 13th European Congress “Metabolic Syndrome and the effect of testosterone treatment in young men with hypogonadotropic hypogonadism”, P562 pp., Rotterdam, The Netherlands, April 2011, in the proceedings booklet “Endocrine Abstracts” within the conference of Endocrinology

15.A. Aydogdu, G. Uckaya, I. Tascı, O. Baysan, S. Tapan, B. Bugan, M. Serdar, S. Aydogdu, H. Akbulut, U. Aydogan, A. Sonmez, O. Azal, 15th International, 14th “Epicardial adipose tissue thickness in patients with polycystic ovary syndrome”, p963 pp., Florence, Italy, May 2012, in the “Endocrine Abstracts” proceedings book within the European Congrees of Endocrinology conference

16.A. Aydogdu, I. Tasci, S. Tapan, Y. Basaran, U. Aydogan, C. Meric, A. Sonmez, S. Aydogdu, H. Akbulut, A Taslipinar, C. Haymana, G. Uckaya, O. Azal, 15th International, 14th European Congrees of Endocrinology conference, “High plasma level of long pentraxin 3 is associated with insulin resistance in womwn with polycystic ovary syndrome”, p964 pp., Florence, Italy, May 2012

17.A. Aydogdu, I. Tascı, O. Kucukerdonmez, S. Tapan, S. Aydogdu, G. Uckaya, C. Meric, Y. Basaran, A. Sonmez, C. Haymana, K. Baskoy, A. Taslıpınar, O. Azal, “Subcutaneous adipose tissue in womwn with polycystic ovary syndrome”, P914 pp., Florence, Italy, May 2012

18.C. Haymana, A. Sonmez, A. Aydogdu, A. Taslıpınar, C. Meric, Y. Basaran, K. Baskoy, S. Tapan, G. Uckaya, E. Bolu, O. Azal, 15th International, 14th European Congrees of Endocrinology “Visceral adiposity index and effect of testosterone treatment in young men with congenital hypogonadotrophic hypogonadism”, P 1047 pp., Florence, Italy, May 2012, in the “Endocrine Abstracts” conference booklet

19.YC Doganer, U. Aydogan, H. Akbulut, P. Nerkız, A. Aydogdu, C. Barcın, S.Tapan, K.Saglam., “Wonca Jeju 2012″ in the proceedings book of the 19th Wonca Asia Passive Regional Conference. Non-HDL Levels in patients who underwent angography and its relationship with atherosclerosis.”, 72 pp., Jeju, Korea, May 2012

20.A. Aydogdu, U. Aydogan, S. Yuksel, H.Akbulut, A.Sonmez, E. Bolu, K. Saglam., “Research of testosterone replacement therapy effects on Arrizona Sexual Experience Scale (Agio) at young patients with hypogonadism”, 102 pp., Jeju, Korea, May 2012

21.YC Doganer, U. Aydogan, H. Akbulut, P. Nerkız, H. Akbulut, A. Aydogdu, S. Tapan, C. Barcın, K., “Wonca Jeju 2012” paper within the 19th Wonca Asia Pasific Regional Conference conference “Lipid profile in patients who underwent angiography and using statin treatment.”, 72 pp., Jeju, Korea, May 2012

22.S. Yuksel, U. Aydogan, A. Aydogdu, H. Akbulut, O. Kucukdonmez, G. Garıpoglu, K. Saglam, M. Kutlu., “Depression and quality” in the booklet “Wonca, Jeju” within the 19th Wonca Asia Passive Regional Conference of life in women with high body mass index”, 1 pp., Jeju, Korea, May 2012

23.S. Yuksel, U. Aydogan, A. Aydogdu, H. Akbulut, E. Bolu, K. Saglam., “The impacts of testosterone theraphy on young hypogonadotrophic hypogonadal mMen” in the proceedings book “Wonca, Jeju” within the 19th Wonca Asia Pacific Regional Conference quality of life”, 3 pp., Jeju, Korea, May 2012

24.YC Doganer, U. Aydogan, H. Akbulut, P. Nerkız, A. Aydogdu, S. Tapan, C. Barcın, K. Saglam, “Total” in the “Wonca, Jeju” proceedings book within the scope of the 19th Wonca Asia Pasific Regional Conference. Cholesterol/HDL ratio among the patients wcarried out an elective coronary angiograhy.”, 45 pp., Jeju, Korea, May 2012

25.YC Doganer, U. Aydogan, H. Akbulut, A. Aydogdu, C. Barcın S. Tapan, K. Saglam, 19th Wonca Asıa Pasific Regional Conference within the “Wonca, Jeju” proceedings booklet “Family history of cardiovascular diseases in patients carried out angiographic intervention”, 14 pp., Jeju, Korea, May 2012

26.YC Doganer, O. Aydogan, P. Nerkız, H. Akbulut, A. Aydogdu, S. Tapan, C. Barcın, K. Saglam., “Wonca, Jeju” in the proceedings book of the 19th Wonca Asia Passive Regional Conference. Is mean platelet volume as an indicator to show the presence of coronary artery disease”, 68 pp., Jeju, Korea, May 2012

27.YC Doganer, U. Aydogan, H. Akbulut, P. Nerkız, A. Aydogdu, C. Barcın S. Tapan, K. Saglam., “Smoking” in the “Wonca, Jeju” proceedings book within the scope of the 19th Wonca Asia Pasific Regional Conference status of patients carried out angiography and relationship with level of atherosclerosis.”, 16 pp., Jeju, Korea, May 2012

28.H. Akbulut, M. Biçer, O. Sarı, Ü. Aydogan, A. Aydoğdu, YCDoğaner, B.Koç, “The Effects of Regular Exercise on the Quality of Life” in the booklet “Abstracts” within the 18th Wonca Europe Conference, 219 pp., Vienna, Austria, July 2012.

29.H. Akbulut, O. Sari, S. Yuksel, U. Aydoğan, M. Goıcut, A. Aydoğdu, YC Doğaner, “The Frequency of Antibiotic Prescriptions in a Family Medicine Center” in the “Abstracts” booklet within the 181h Wonca Europe Conference, 224 pp., Vienna, Austria, July 2012.

30.Eroglu A, Yıldız Y, Orscelik A, Aydogan U, Engin Gok D, Akbulut H, Aydogdu A, Sonmez A, Bolu E, Aydın T. Comparison of isokinetic muscle strength relation between hypogonad indiviguals and the healthy recreational athletes. 17th Wonca Europe Conference, Poland.8-11 September 2011.

31.Eroglu A, Aydogan U, Akbulut H, Aydogdu A, Kucukerdonmez O, Garipoglu G, Saglam K, Kutlu M. The sociodemographic attributes of obese individuals and the evaluation of their behavior and attitude towards obesity. 17th Wonca Europe Conference, Poland.8-11 September 2011.

32.Kocaciftci G, Akbulut H, Aydogan U, Kavuk S, Sari O, Aydogdu A, Engin Gok D, Sahin E, Saglam K. The effect of metformin and metformin+calcium treatment on the Vit B12 Levels. 17th Wonca Europe Conference, Poland.8-11 September 2011.

33.Kocaciftci G, Akbulut H, Aydogan U, Tanrıover M, Sari O, Aydogdu A, Engin Gok D, Sahin E, Saglam K. The effect of metformin therapy to blood parameters in patients with impaired glucose metabolism. 17th Wonca Europe Conference, Poland.8-11 September 2011.

34.YC Doğaner, U. Aydoğan, A. Aydoğdu, H. Akbulut, Tapan S, C. Barçın, K. Sağlam, K. Comparison of coronary artery disease (CAD) severity with previous cardiac histories. 20th Wonca 2013 Prague 25-29 June 2013.

35.YC Doğaner, U. Aydoğan, Nerkiz P, H. Akbulut, A. Aydogdu, T Cayci, C. Barçın, K. Sağlam, K. Evaluation of the relation between severity of coronary artery disease and glomerular filtration rate. 20th Wonca 2013 Prague 25-29 June 2013.

36.A. Aydogdu, U. Aydogan, H. Akbulut, S. Tapan, G. Uckaya, YC Doganer, C. Barcın, A. Taslıpinar, C. Meric, A. Sonmez, M. Kutlu. Low stweak levels in coronary atherosclerosis. Abstracts of the 7th Metabolic Syndrome Symposium, Obesity reviews, 29 april-2 May 2010, Copenhagen.

37.A. Aydogdu, U. Aydogan, H. Akbulut, Y. Basaran, C. Barcın, S. Aydogdu, I. Tascı, G. Uckaya, A. Sonmez, S. Tapan, C. Meric, O. Azal. Is coronary artery disease a risk factor for hypogonadism? 19th Wonca Asia Pacific Regional Conference. May24-27, 2012, International Convention Center Jeju, Korea.

1. Erol Bolu, Alper Sonmez, SerkanTapan, Abdullah Taslipinar, Aydogan Aydogdu, Coskun Meric, Yalcin Basaran, Gökhan Uckaya, Muhittin A Serdar, Ismail Kurt, Omer Azal. HDL cholesterol subfractions and the effect of testosterone replacement in hypogonadism.15th EuropeanCongress of Endocrinology. Endocrine Abstracts, 27 April-1 May 2013, Copehagen, Denmark. (Horm Metab Res. 2013 Jun;45(6):443-8.Doi: 10.1055/s-0033-1343447).

39.Aydogan Aydogdu, Coskun Meric, Kamil Baskoy, Tural Ibrahimov, Cem Haymana, Zafer Kilbas, Ahmet Karakas, Mehmet Gamsizkan, Abdullah Taslipinar, Y. Alper Sonmez, Omer Azal. Bilateral adrenal masses presenting with primary adrenal insufficiency and meningoencephalitis: a case report of disseminated cryptococcosis. Endo Bridge 2013, 23-26 October, 2013, Antalya, Turkey.

40.A. Sonmez, C. Haymana, A. Aydogdu, S. Tapan, Y. Basaran, C. Meric, K. Baskoy, A. Taslipinar, O. Azal. Effect of testosterone replacement treatment on the ADMA, FGF 23 and vitamin D levels in hypogonadism.82nd. EAS Congress, May 31-June 3, 2014, Madrid, SPAIN.

41.C. Meric, A. Sonmez, A. Aydogdu, S. Tapan, C. Haymana, Y. Basaran, K. Baskoy, E. Sertoglu, A. Taslipinar, E. Bolu, O. Azal. Osteoprotegerin, fibroblast growth factor 23 and vitamin D3 levels in male patients with hypogonadism. 82nd. EAS Congress, May 31-June 3, 2014, Madrid, SPAIN. Horm Metab Res. 2014 Sep 2. (Epub ahead of print); doi:10.1055/s-0034-1387789.

42.C Meric, A. Aydoğdu, I. Tasci, F. Deniz, O. Baysan, M. Serdar, K. Saglam, O. Azal. Effects of valsartan treatment on serum ghrelin level and left ventricular mass index in patients with untreated primary hypertension. 82nd. EAS Congress, May 31-June 3, 2014, Madrid, SPAIN. (Anadolu Kardiyol Magazine 2014; 14: 234-8. Doi: 10.5152/akd.2014.4738)

43.Alper Sonmez, Cem Haymana, Aydogan Aydogdu, Serkan Tapan, Yalcin Basaran, Coskun Meric, Kamil Basköy, Mustafa Dinc, Mahmut Yazici, Abdullah Taslipinar, Omer Azal. Endothelial dysfunction, insulin resistance and inflammation are present in young patients with congenital hypogonadism and do not improve after the testosterone replacement therapy. 16 th International Congress of Endocrinology (ICE)-ENDO 2014, June 21-24, 2014, CHICAGO.

44.Yalcin Basaran, Abdullah Taslipinar, Sinasi Erol Bolu, Mehmet Ali Saracli, Turker Turker, Coskun Meric, Cem Haymana, Kamil Baskoy, Mustafa Dinc, Ferhat Deniz, Mahmut Yazici, Aydogan Aydogdu, Alper Sonmez, Omer Azal. Comparison of gut microbiota in obese, diabetic and healthy control induviduals. 16 th International Congress of Endocrinology (ICE)-ENDO 2014, June 21-24, 2014, Chicago.

45.Mustafa Dinc, Aydogan Aydogdu, Erot CF, Erol Aslan, Yalcin Basaran, Cem Haymana, Abdullah Taslipinar, Alper Sonmez, Mahmut Yazici, Omer Azal Case with hyperamilasemia thought to be assoscited with prednisolone use. 14th European Congress of Internal Medicine, Moscow, Russia.

46.Mustafa Dinc, Aydogan Aydogdu, Erol Aslan, Alper Sonmez, Yalcin Basaran, Cem Haymana, Abdullah Taslipinar, Mahmut Yazici, Omer Azal. Klippel Trenaunay Seyndrome, A rare cause of extremity growth. 14th European Congress of Internal Medicine, Moscow, Russia.

47.Cem Haymana, Aydogan Aydogdu, Bugra Soykut, Onur Erdem, Tural Ibrahimov, Mustafa Dinc, Coskun Meric, Abdullah Taslipinar, Yalcin Basaran, Alper Sonmez, Omer Azal. Investigation of Oxidative stress related parameters in congenital hypogonadism. 18th Congress of Endocrinology, 28-21 May, Munich, Germany.

48.Cem Haymana, Alper Sonmez, Aydogan Aydogdu, Serkan Tapan, Yalcin Basaran, Coskun Meric, Kamil Baskoy, Mustafa Dinc, Abdullah Taslipinar, Cem Barcin, M Ilker Yılmaz, Sinasi Erol Bolu, Omer Azal. Role of Visceral adiposity index and triglyceride/HDL-C levels in predicting endothelial dysfunction, inflammation and insulin resistance in hypogonadism. ENDO 5-8 March 2015, San Diego.

49.Aydogan Aydogdu, Cem Haymana, Serkan Tapan, Alper Sonmez, Omer Azal. Increased Visceral adiposity index in patients with PCOS; relation between inflammation, insulin resistance and hyperandogenity. 82nd EAS congress May 31-June 3, 2014 Madrid, Spain.

Chapters Written in National and International Books

1. Authors: Aydoğan Aydoğdu, Ahmet Çorakçı. Editor: Metin Özata Endocrinology Metabolism and Diabetes (Insulin treatment in diabetes), 583-599 pp., Istanbul, Istanbul Medicine Bookstore, 2011.

2.Authors: Ömer Azal, Aydoğan Aydoğdu. Editor: Metin Özata. Endocrinology Metabolism and Diabetes (Diabetic Nephropathy), 601-608 pp., Istanbul, Istanbul Medicine Bookstore, 2011.

3.Authors: Erol Bolu, Aydogan Aydoğdu. Editor: Temel Yilmaz. Year Book of Turkish Diabetology (Hunger Hypoglycemia), 7-12 pp., Istanbul, Turkish Diabetes Foundation, 2008-2009.

4.Omer Azal, Aydogan Aydogdu. Editor: Temel Yılmaz, Year Book of Turkish Diabetology (Cardiovascular Effects of Hyperglycemia), 13-20 pp., Istanbul, Turkish Diabetes Foundation, 2008-2009.

1. Authors: Ömer Azal, Aydoğan Aydoğdu. Editor: Temel Yılmaz, Year Book of Turkish Diabetology (Diabetic Nephropathy Treatment), 159-165 pp., Istanbul, Turkish Diabetes Foundation, 2009-2010.

2. Aydogan Aydogdu. Basic Family Medicine Book, 2015 1st Edition Ed. Ümit Aydoğan, Bayram Koç, Chapter 8 Endocrine and Metabolic Diseases, Author of the Chapter: Approach to hypoglycemia Güneş Medical Publishing House

7.Lipid Metabolism Disorders Diagnosis and Treatment Guide, 2016 Obesity, Dyslipidemia, Hypertension Working Group, Fahri Bayram, Tevfik Sabuncu, Yusuf Özkan, Cumali Gökçe, Mustafa Cesur, Alper Sönmez, Aydoğan Aydoğdu, Sibel Ertek, Ufuk Özuğuz, Ayşenur İzel Grandson İbrahim Arslan, Rıfkı Üçler. Pelin Ofset Printing, Ankara ISBN: 978-605-4011-23-0

8.Aydogan Aydogdu, Ahmet Corakci. Editor: Metin Özata. Endocrinology, Metabolism and Diabetes, 3rd Edition Insulin Therapy in Diabetes (Updated New Edition), Istanbul, Istanbul Medicine Bookstore, 2016

1. Aydogan Aydogdu, Omer Azal. Editor: Metin Özata. Endocrinology, Metabolism and Diabetes, 3rd Edition, Diabetic Nephropathy (Updated New Edition), Istanbul, Istanbul Medicine Bookstore, 2016

Chapter Translator of Any Book in the Field

1.Aydoğan Aydoğdu, Gökhan Üçkaya, Ahmet Çorakçı (Chapter Translated), Book Editors: DG Gardner, D. Shoback. Translation editor: Metin Arslan. Lange Basic and Clinical Endocrinology (Pancreatic Hormones and Diabetes Mellitus), 661-745 pp., Ankara, Güneş Medical Publishing House, 2009.

Articles published in national peer-reviewed journals

1.Aydoğdu A, G. Üçkaya, Ü. Aydoğan, A. Taşlıpınar, A. Sönmez, M. Kutlu, “Subclinical hypothyroidism may not cause dyslipidemia in women”, Turkish Journal of Family Medicine, 162-166 pp., 2010, DOI: 10.2399/tahd.10.162

2.Aydoğdu A, C. Meriç, R. Yıldız, G. Üçkaya, R. Acar, A. Sönmez, A. Taşlıpınar, Ü. Aydogan, H. Akbulut, O. Öngürü, M. Kutlu, “Parathyroid cancer case”, Gülhane Medical Journal, 139-142 pp., 2011.

3.YM Yarpuz, Ü. Aydoğan, O. Sarı, A. Aydoğdu, G. Üçkaya, A. Fenercioğlu, DA Yarpuz, K. Sağlam, “Effect of Thyroid Replacement Therapy on Anxiety and Depression Levels in Patients with Subclinical Hypothyroidism”, Clinical Psychiatry, 180-187 pp., 2009.

4.U. Aydoğan, S. Mutlu, H. Akbulut, G. Taş, A. Aydoğdu, K. Sağlam, “Anxiety Disorder in Hypertension Patients”, Konuralp Medical Journal, 1-5 pp., 2012.

5.Ergün DEMIRALP, R. Eralp ULUSOY, Ata KIRILMAZ, Ejder KARDEŞOĞLU, Namık ÖZMEN, Özcan KESKIN, M. Nezihi KÜÇÜKARSLAN, Aydoğan AYDOGDU, Mehmet DINÇTURK. Familial Mediterranean fever acute crisis prolongs the QT interval. Göztepe Medical Journal 20(1):32-35, 2006.

1. Halil Akbulut, Aydoğan Aydoğdu, Ümit Aydoğan, Cem Barçın, Serkan Tapan, Yusuf Çetin Doğaner, Türker Türker, Tuncer Çaycı, Ersoy Işık, Hürkan Kürşaklıoğlu. Kenan Sağlam The Relationship Between Coronary Artery Disease and Undiagnosed Glucose Metabolism Disorders in Patients who Have Undergone Angiography, Turk Jem 2013; 17:111-115.

7.Cem Haymana, Aydogan Aydogdu, Ilker Tasci, Umut Safer, Tural Ibrahimov, Mustafa Dinc, Fatih Yesildal, Serkan Tapan, Kayihan Kara, Coskun Meric, Omer Azal. Assessment of a low ankle brachial index in young males with congenital hypogonadism Gülhane Medicine Journal 2017;59: 11-15.

8.Cem Haymana, Alper Sönmez, Aydoğan Aydoğdu, Abdullah Taşlıpınar, Coşkun Meriç, Yalçın Başaran, Mustafa Dinç, Orhan Demir, Ömer Azal, Serkan Tapan. Effect of testosterone replacement therapy on inflammation and insulin resistance in patients with congenital hypogonadotropic hypogonadism. Gulhane Medical Journal 2016;58:394-397.

1. Increased visceral adiposity index in cases of polycystic ovary syndrome; The relationship between inflammation, insulin resistance and hyperandrogenicity. Aydoğan Aydoğdu, Cem Haymana, Serkan Tapan, Abdullah Taşlıpınar, Mahmut Yazıcı, Yalçın Başaran, Mustafa Dinç, Alper Sönmez, Ömer Azal. Gulhane Medical Journal 2015;57: 107 – 110.

Papers presented at national scientific meetings and published in proceedings books

1.A Aydoğdu, H. Akbulut, A. Taşlıpınar, Ü. Aydogan, G. Uckaya, S. Aydoğdu, A. Sönmez, K. Sağlam, M. Kutlu., “Increased incidence of epin calcanei in Type 2 Diabetes patients” in the “PROGRAM AND SUMMARY BOOK” booklet within the 45th National Diabetes Congress conference, 189 pp., Antalya; Türkiye, May 2009

2 A. Sönmez, S. Tapan, U. Safer, G. Çelebi, C. Haymana, T. Doğru, G. Erdem, İ. Taşçı, A. Taşlıpınar, A. Aydogdu, Ö. Ozturk, I. Kurt, M. Kutlu, “A new marker for endothelial dysfunction and inflammation in Type 2 Diabetes cases: Chitothyrosidase”, 142 pp., Antalya, Turkey, May 2009

3 A. Sönmez, Z. Yılmaz, G. Üçkaya, S. Tapan, S. Kılıç, A. Taşlıpınar, A. Aydoğdu, M. Yazıcı, H. Turan, E. Bolu, Ö. Azal, A. Çorakçı, MK Erbil, M. Kutlu., “Can personal glucose measurement devices accurately detect hypoglycemia?”, 145 pp., Antalya, 2009, May 2009

4.A. Sönmez, Z. Yılmaz, G. Üçkaya, S. Kılıç, S. Tapan, A. Taşlıpınar, A. Aydoğdu, M. Yazıcı, M. İ. Yılmaz, M. Serdar, MK Erbil, M. Kutlu, “Are glucose measuring devices sensitive enough to hypoglycemia?”, 74 pp., in the “Program and summary book” proceedings book within the 46th National Diabetes Congress conference, Antalya, Turkey, May 2010

5 A. Aydogdu, S. Aydoğdu, G. Üçkaya, A. Sönmez, C. Meriç, A. Taşlıpınar, Ü. Aydogan, H. Akkaya, O. Azal, A. Çorakçı, M. Yıldız, M. Kutlu., “The frequency of prediabetes and diabetes mellitus in young obese men.”, in the “Book of Proceedings and Speech Summaries” within the 32nd Turkish Congress of Endocrinology and Metabolic Diseases Conference, 104 pp., Antalya, Turkey, OCTOBER 2010

6.A. Aydoğdu, E. Bolu, G. Üçkaya, R. Acar, A. Sönmez, C. Meriç, A. Taşlıpınar, M. Yazıcı, M. Kutlu., “Proceedings and speech summaries within the 32nd Turkish Endocrinology and Metabolic Diseases Congress conference” “Effects of testosterone (t) and human chorionic gonadotropin (HCG) treatments on gonadotropin levels and testicular volumes (tv)”, 145 pp., Antalya, 2010, October 2010

7.A. Aydogdu, H. Akbulut, U. Aydoğan, E. Bolu, G. Üçkaya, A. Sönmez, A. Taşlıpınar, O. Sarı, Ş. Aydoğdu, K. Sağlam, M. Kutlu., “Prevalence of depression in newly diagnosed hypogonad patients.”, 146 pp., Antalya, 2010, October 2010

8.U. Aydogan, A. Aydogdu, H. Akbulut, O. Küçükdönmez, S. Yüksel, G. Garipoğlu, K. Sağlam, M. Kutlu., “Depression and quality of life levels in obese patients” in the “Proceedings and speech summaries” booklet within the 32nd Turkish Endocrinology and Metabolic Diseases Congress conference, 128 pp. ., Antalya, Turkey, October 2010

9.C. Meriç, A. Aydoğdu, A. Selçuk, MF Can, S. Çetiner, T. Özgürtaş, G. Üçkaya, M. Kutlu, within the scope of the 32nd Turkish Endocrinology and Metabolic Diseases Congress conference, “Localize Confirmation of the success of exploratory surgery with intraoperative insulin measurement in an undiagnosed insulinoma case.”, 112 pp., Antalya, 2010, October 2010

10.C. Meriç, A. Aydoğdu, BB Başgöz, N. Ersöz, Z. Çapa, B. Karaman, G. Üçkaya, S. Çetiner, M. Kutlu, 32nd Turkish Endocrinology and Metabolic Diseases Congress, conference “Book of abstracts and speeches ” “A rare case: nesidioblastosis in adult” in the proceedings booklet, 99 pp., Antalya, Turkey, October 2010

11.C. Meric, A. Aydogdu, U. Cintosun, G. Üçkaya, A. Taşlıpınar, YA Sonmez, Ş. E. Bolu, O. Azal, A. Çorakçı, M. Kutlu, “A case of hyponatremia dependent on endogenous hyperinsulinism.”, 92 pp., in the “Proceedings and Speech Summaries” booklet within the 32nd Turkish Congress of Endocrinology and Metabolic Diseases Conference, Antalya, Turkey, October 2010

12.İ. Ertürk, G. Taşkın, C. Meriç, A. Aydoğdu, G. Üçkaya, H. Erdem, S. Sayın, M. Kutlu, “Proceedings and speech summaries book” in the conference booklet of the 32nd Turkish Endocrinology and Metabolic Diseases Congress. Case Report: Erythema nodosum accompanying granulomatous mastitis in a patient with Type 1 Diabetes Mellitus.”, 106 pp., Antalya, Turkey, October 2010

13.A. Sönmez, C. Haymana, E. Bolu, A. Aydoğdu, S. Tapan, B. Altun, C. Barçın, A. Taşlıpınar, C. Meriç, G. Üçkaya, M. Serdar, M. Kutlu, 32. Turkey Endocrinology And “Metabolic syndrome criteria and investigation of metabolic effects of testosterone treatment in young hypogonads” in the “Proceedings and speech summaries book” within the conference of Metabolic Diseases Congress, 139 pp., Antlya, Turkey, October, 2010

14.A. Aydoğdu, U. Aydoğan, H. Akbulut, C. Barçın, G. Üçkaya, A. Sönmez, S. Aydoğdu, B. Bugan, A. Taşlıpınar, C. Meriç, H. Kurşaklıoğlu, M. Kutlu, 26. National Cadiology “Evaluation of testosterone levels in patients with coronary artery disease” in the “Congress Abstract Booklet” within the scope of the congress conference, 280 pp., Istanbul, Turkey, May 2010

15.A. Sönmez, C. Meriç, S. Tapan, A. Taşlıpınar, Z. Yılmaz, O. Eraslan, A. Aydogdu, Y. Başaran, MI Yılmaz, Ö. Azal., “Comparison of type 2 dm cases using vildagliptin or gliclazide in addition to metformin treatment in terms of inflammation and endothelial dysfunction” in the “Proceedings and Speech Summaries” of the 33rd Turkish Endocrinology and Metabolic Diseases Congress conference, 185 pp., Antalya, Turkey , October 2011

16.A. Aydoğdu, G. Üçkaya, O. Baysan, S. Tapan, B. Bugan, M. Serdar, H. Akbulut, Ü. Aydogan, A. Sonmez, S. Aydoğdu, C. Meriç, M. Kutlu., “The relationship of epicardial adipose tissue thickness with Homa–IR and adiponectin levels in polycystic ovarian syndrome cases” in the “Book of Proceedings and Speech Summaries” within the scope of the 33rd Turkish Endocrinology and Metabolic Diseases Congress conference, 236 pp., Antalya, Turkey, October 2011

17.A. Aydogdu, I. Tasci, S. Tapan, A. Sonmez, U. Aydogan, H. Akbulut, Y. Basaran, G. Uckaya, S. Aydogdu, A. Taslipinar, I. Kurt, O. Azal., “Increased plasma chitothosidase activity in women with polycytic ovary syndrome: Physiopathological relationship between inflammation and impaired insulin sensitivity”, 237 pp., Antalya, Turkey, within the conference of the 33rd Turkish Congress of Endocrinology and Metabolic Diseases. October 2011

18th century Başaran, A. Sönmez, A. Aydoğdu, C. Meriç, S.Tapan, A. Taşlıpınar, C. Haymana, G. Üçkaya, G. Büyükturan, T. Özgürtaş, E. Bolu, Ö. Azal., “The effect of two different testosterone administration on metabolic parameters in hypogonadism treatment”, 229 pp., Antalya, Turkey, October 2011

19.C. Meriç, A. Sönmez, A. Aydoğdu, Y. Başaran, C. Haymana, S. Tapan, A. Taşlıpınar, G. Üçkaya, T. Özgürtaş, E. Bolu, Ö. Azal., “Metabolic parameters and the effect of testosterone therapy in young men with congenital hypogonadotropic hypogonadism” in the “Book of Proceedings and Speech Summaries” of the 33rd Turkish Congress of Endocrinology and Metabolic Diseases conference, 231 pp., Antalya, Turkey, October 2011

20.E. Bolu, A. Sönmez, S. Tapan, A. Taşlıpınar, A. Aydoğdu, C. Meriç, Y. Başaran, G. Üçkaya, M. Serdar, İ. Kurt, O. Azal., “The effect of HDL subgroups and testosterone replacement therapy in hypogonadism cases” in the “Proceedings and speech summaries” booklet of the 33rd Turkish Endocrinology and Metabolic Diseases Congress conference, 240 pp., Antalya, Turkey, October 2011

21.A. Sönmez, A. Taşlıpınar, A. Aydoğdu, S. Tapan, C. Meriç, Y. Başaran, M. İ. Yılmaz, T. Özgürtaş, M. Serdar, E. Bolu, M. Kutlu, Investigation of inflammation, insulin resistance and endothelial dysfunction in male patients with hypogonadism in the “Proceedings and Speech Summaries” booklet of the 33rd Turkish Congress of Endocrinology and Metabolic Diseases. “, 243 pp., Antalya, Turkey, October 2011

22.A. Sönmez, A. Taşlıpınar, A. Aydoğdu, S. Sapan, C. Meriç, Y. Başaran, E. Sertoğlu, M.İ. Yılmaz, M. Serdar, S. Özgürtaş, E. Bolu, M. Kutlu., “The effect of testosterone treatment on endothelial dysfunction, inflammation and insulin resistance in male hypogonadotropic hypogonadism” in the “Proceedings and speech summaries book” within the context of the 33rd Turkish Congress of Endochronology and Metabolic Diseases. effects”, 97 pp., Antalya, Turkey, October 2011

23.A. Aydogdu, H. Akbulut, U. Aydogan, C. Barçın, H. Kuşaklıoğlu, C. Doğaner, T. Çaycı, O. Sarı, A. Sönmez, G. Üçkaya, K. Sağlam, M. Kutlu., “Previously unknown glucose in coronary artery patients” in the “Program and summary book” within the 47th National Diabetes Congress conference metabolic disorders and their relationship with coronary artery disease”, 78 pp., Antalya, Turkey, May 2011

24.A. Aydogdu, O. Kucukerdonmez, I. Taşçı, S. Tapan, G. Üçkaya, Ş. Aydogdu, U. Aydogan, A. Sonmez, C. Meric, M. Yazici, E. Bolu, O. Azal., “The relationship of increased subcutaneous adipose tissue and muscle tissue with insulin resistance in polycystic ovary syndrome cases.”, S31 pp., Antalya, Turkey, April 2012

25.A. Aydoğdu, E. Bolu, A. Sönmez, C. Haymana, R. Öcal, C. Meriç, Y. Başaran, A. Taşlıpınar, K. Başköy, G. Üçkaya, T. Özgürtaş, Ö. Azal., “The effects of different treatment options in hypogonadotropic hypogonadism cases.”, S30 pp., Antalya, Turkey, April 2012

26.A. Aydogdu, I. Taşçı, A. Sonmez, S. Tapan, Y. Başaran, C. Meriç, Ş. Aydoğdu, C. Haymana, M. Yazıcı, G. Üçkaya, E. Bolu, O. Azal., “Increased plasma pentraxin 3 levels in cases with polycystic ovary syndrome” in the “Proceedings and speech summaries” booklet within the context of the 34th Endocrinology and Metabolic Diseases Congress conference. associated with insulin resistance.”, p028 pp., Antalya, Turkey, April 2012

27.C. Haymana, A. Sonmez, A. Aydoğdu, C. Meriç, Y. Başaran, K. Başköy, A. Taşlıpınar, S. Tapan, G. Üçkaya, E. Bolu, Ö. Azal., “Visceral adiposity index levels in patients with congenital hypogonadotropic hypogonodism and the effects of testosterone therapy.”, P026 pp., Antalya, Turkey, April 2012

28.H. Akbulut, K. Uyanık, Ü. Aydoğan, GE Yıldırım, N. Yıldırım, A. Aydoğdu, O. Sarı., “Sleep quality in individuals who smoke” in the “Congress Book” proceedings book within the 7th International Istanbul Family Medicine Congress conference, P16 pp., Istanbul, Turkey, April 2012

29.A. Aydogdu, I. Tasci, A. Sonmez, S. Sapan, S. Aydoğdu, M. Yazıcı, C. Meriç, K. Başköy, G. Üçkaya, A Taşlıpınar, E. Bolu, Ö. Azal, “Reduced TWEAK level correlates with insulin resistance in polycystic ovarian syndrome cases.”, 132 pp., Antalya, Turkey, May 2012.

30.Coşkun Meriç, Yusuf Alper Sönmez, Aydoğan Aydoğdu, Serkan Tapan, Cem Haymana, Yalçın Başaran, Kamil Başköy, Erdim Sertoğlu, Abdullah Taşlıpınar, Şinasi Erol Bolu, Ömer Azal. Investigation of osteoprotegerin, fibroblast growth factor-23 and vitamin D3 levels in male hypogonadism cases. 35. Turkish Endocrinology and Metabolic Diseases Congress & Pituitary Symposium, Congress Book, 15-19 May, 2013, Antalya, Turkey.

31.Coşkun Meriç, Aydoğan Aydoğdu, İlker Taşçı, Oben Baysan, Ferhat Deniz, Muhittin Serdar, Enan Sağlam, Ömer Azal. The effects of valsartan on serum ghrelin level and left ventricular mass index in untreated primary hypertensive patients. 35. Turkish Endocrinology and Metabolic Diseases Congress & Pituitary Symposium, Congress Book, 15-19 May, 2013, Antalya, Turkey

32.Aydoğan Aydoğdu, Cem Haymana, Serkan Tapan, Abdullah Taşlıpınar, Mahmut Azıcı, Coşkun Meriç, Alper Sönmez, Ömer Azal. The relationship between increased visceral adiposity index, inflammation, insulin resistance and hyperandrogenicity in patients with polycystic ovary syndrome. 36. Turkey Congress of Endocrinology and Metabolic Diseases, Congress Book, 21-25 May, 2014, Antalya, Turkey.

33.Aydoğan Aydoğdu, Coşkun Meriç, Kamil Başköy, Cem Haymana, Ahmet Karakaş, Zafer Kılbaş, Mehmet Gamsızkan, Abdullah Taşlıpınar, Alper Sönmez, Ömer Azal. Bilateral adrenal mass and adrenal insufficiency: a case report. 36. Turkey Congress of Endocrinology and Metabolic Diseases, Congress Book, 21-25 May, 2014, Antalya, Turkey.

34.Yalçın Başaran, Abdullah Taşlıpınar, Erol Bolu, Mehmet Ali Saraçlı, Türker Türker, Coşkun Meriç, Cem Haymana, Kamil Başköy, Mahmut Yazıcı, Aydoğan Aydoğdu, Alper Sönmez, Ömer Azal. Comparison of the gut microbiota of obese, diabetic and healthy individuals.36. Turkish Endocrinology and Metabolic Diseases Congress, Congress Book, 21-25 May, 2014, Antalya, Turkey.

1. Yusuf Alper Sonmez, Cem Haymana, Aydoğan Aydoğdu, Serkan Tapan, Yalçın Başaran, Coşkun Meriç, Kamil Başköy, Abdullah Taşlıpınar, Ömer Azal. The effect of testosterone treatment on plasma ADMA, FGF-23 and vitamin D levels in young hypogonad patients. 36. Turkey Congress of Endocrinology and Metabolic Diseases, Congress Book, 21-25 May, 2014, Antalya, Turkey.

36.Alper Sonmez, Mustafa Dinc, Abdullah Taslipinar, Aydogan Aydogdu, Coskun Meric, Yalcin Basaran, Cem Haymana, Orhan Demir, Mahmut Ilker Yilmaz, Omer Azal. Addition of Exenatide to Intensive Insulin Therapy in Obese Patients with Uncontrolled Type 2 Diabetes. 52nd National Diabetes Congress, 20-24 April 2016, Antalya, Turkey.

1. Özge Küçükerdönmez, Aydoğan Aydoğdu, İbrahim Demircı, Alper Sönmez, Gökhan Üçkaya, Erol Bolu, Ömer Azal. Fat Tissue Increase and Insulin Resistance in Patients with Hypogonadism 39. Turkey Endocrinology and Metabolic Diseases Congress, Congress Book, 3-7 May, 2017, Antalya, Turkey.

38.Cem Haymana, Aydoğan Aydoğdu, İbrahim Demircı, Mustafa Dinç, Orhan Demir, Deniz Torun, Fatih Yeşildal, Coşkun Meriç, Yalçın Başaran, Alper Sönmez, Ömer Azal. Endothelial Dysfunction, Insulin Resistance and Inflammation in Patients with Klinefelter Syndrome. 39. Turkey Congress of Endocrinology and Metabolic Diseases, Congress Book, 3-7 May, 2017, Antalya, Turkey.

39.Aydogan Aydoğdu, Jonas Ceponis, Ronald S. Swerdloff, Christina Wang, Youngju Pak, Indre Ceponiene, Dong Li, Dhananjay VaiDya, Jingzhong Ding, Matthew J. Budoff Mesa (Multi-Ethnic Study of Atheros Studies of Men with Atheros) The Relationship Between Pericardial Adipose Tissue and 39. Turkey Endocrinology and Metabolic Diseases Congress, Congress Book, 3-7 May, 2017, Antalya, Turkey.

1. İbrahim Demircı, Cem Haymana, Alper Sonmez, Abdullah Bolu, Nazlı Gülsoy Kırnap, Orhan Demir Mustafa Dinç, Coşkun Meriç, Aydoğan Aydoğdu, Ömer Azal. Depressive illness screening in adult diabetes patients 53rd Diabetes Congress, 19-23 April 2017 Girne, Cyprus.

Speeches at national meetings

1st Session Chairman, Gübat 9. First presentation days 5 March 2011-Obesity:

1. Speaker, 35th Turkish Congress of Endocrinology and Metabolic Diseases, 15-19 May 2013, Approach to Pregnant Women with Congenital Adrenal Hyperplasia and Adrenal Insufficiency

3.3. Tekirdağ Endocrinology Course, 21-22 November 2014, Hypertension Update

1. Speaker, 36th Turkish Congress of Endocrinology and Metabolic Diseases, 15-19 May 2014, Fertility Treatment with Cases; A case with polycystic ovary

5th Session Chairman, 50th National Diabetes Congress 23-27 April 2014, Evaluation of Poster Presentations, Session Chairman

1. Speaker, 37. Turkish Congress of Endocrinology and Metabolic Diseases, 06-10 May 2015, Frequently Used Endocrinological Tests; Test Activity & Patient Activity

7th Session Presidency, 37th Turkish Congress of Endocrinology and Metabolic Diseases, 06-10 May 2015, Frequently Used Endocrinological Tests; Test Activity & Patient Activity

8th Session Chair, 51st National Diabetes Congress, 22-26 April 2015, Poster Presentations Evaluation

1. Speaker, 12. Postgraduate Hypertension Course, ABANT, 30 May 2015, Who should we investigate secondary hypertension?

10.Speaker, 38. Turkish Endocrinology and Metabolic Diseases Congress, 11-15 May 2016, Do we apply nanpharmacological treatment enough in dyslipidemia?

11.Speaker-5. Lipid metabolism disorders training course, ADANA, 17-18 December 2016, Dyslipidemia Definition, Etiology and Classification.

12.Speaker-1. Giresun Endocrinology and Metabolism Conference, 29 December 2016, Approach to Diabetic Patient.

1. 1. Postgraduate Hypertension Course, MUĞLA 11 March 2017, Who should we investigate secondary hypertension?

2. Speaker, 39. Turkey Congress of Endocrinology and Metabolic Diseases, 3-7 May 2017, Reproductive endocrinology and fertility, Man approach.

3. Speaker, 53. National Diabetes Congress, 19-23 April 2017, Pregnant with microvascular complications, Neuropathy.

16th Session Chairman, 5th Adrenal Gonad Symposium, ERZURUM 25 February 2017, Adrenal and intensive care.

17.Speaker-6 Lipid metabolism disorders training course, EDİRNE 15-16 April 2017, Dyslipidemia Definition, Etiology and Classification.

18.Insulin Infusion Models, 2nd Diabetes Treatment Symposium, 17-18 November 2017, ANKARA

19.Principles of Male Sex Hormone Replacement Therapy 6th Adrenal Gonad Symposium, 16 December 2017, ADANA

1. When and How Should We Investigate Secondary Hypertension in Who? 16. Hypertension Training Course 31 March-01 April 2018, ÇORLU/TEKİRDAĞ

21.Sex Hormone Replacement and Erectile Dysfunction Treatment in the Elderly Man, 6th Adrenal Gonad Symposium 23-24 February 2018, ISTANBUL

1. Hypogonadotropic Hypogonadism or Delayed Puberty, 40th National Endocrinology Congress, 09-12 May, ANTALYA

23.Diabetic Dyslipidemia, Definition, Frequency, Etiology 3rd Diabetes Treatment Symposium, 16-17 November 2018, ANKARA

H. Speeches at international meetings

1.BIT s 3rd Annual World Congress of Endobolism-May 20-23, 2013

2.EndoBridge Antalya, 23-26 Oct., 2014